Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels-Reference-Cited by-同舟云学术

Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels

Published:2023-08 Issue: Volume:94 Page:104692
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Murray Aoife^ORCID,Gough Gillian^ORCID,Cindrić Ana^ORCID,Vučković Frano,Koschut David^ORCID,Borelli Vincenzo^ORCID,Petrović Dražen J.,Bekavac Ana^ORCID,Plećaš Ante^ORCID,Hribljan Valentina,Brunmeir Reinhard,Jurić Julija,Pučić-Baković Maja,Slana Anita,Deriš Helena^ORCID,Frkatović Azra,Groet Jűrgen,O’Brien Niamh L.^ORCID,Chen Hong Yu,Yeap Yee Jie,Delom Frederic,Havlicek Steven,Gammon Luke,Hamburg Sarah,Startin Carla^ORCID,D’Souza Hana,Mitrečić Dinko^ORCID,Kero Mijana,Odak Ljubica,Krušlin Božo,Krsnik Željka,Kostović Ivica,Foo Jia Nee,Loh Yuin-Han,Dunn Norris Ray,de la Luna Susana,Spector Tim,Barišić Ingeborg,Thomas Michael S.C.,Strydom Andre^ORCID,Franceschi Claudio,Lauc Gordan,Krištić Jasminka^ORCID,Alić Ivan^ORCID,Nižetić Dean^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference82 articles.

1. Down syndrome;Antonarakis;Nat Rev Dis Primers,2020

2. 2001 William Allan Award address. From Down syndrome to the "human" in "human genetics";Epstein;Am J Hum Genet,2002

3. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome;Wiseman;Nat Rev Neurosci,2015

4. Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system?;Cuadrado;Clin Immunol Immunopathol,1996

5. Bone mineral density and respiratory muscle strength in male individuals with mental retardation (with and without Down Syndrome);da Silva;Res Dev Disabil,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosomal and cellular therapeutic approaches for Down syndrome: A research update;Biochemical and Biophysical Research Communications;2024-11

2. Lamivudine modulates the expression of neurological impairment-related genes and LINE-1 retrotransposons in brain tissues of a Down syndrome mouse model;Frontiers in Aging Neuroscience;2024-07-19

3. IgG1 glycosylation highlights premature aging in Down syndrome;Aging Cell;2024-04-15

4. Down syndrome-associated leukaemias: current evidence and challenges;Therapeutic Advances in Hematology;2024-01

5. Can we suppress chronic systemic inflammation and postpone age-related diseases by targeting the IgG glycome?;Expert Opinion on Therapeutic Targets;2023-10-28